XML 79 R9.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Millions
Total
Common Stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2020   199,438,098      
Beginning balance at Dec. 31, 2020 $ 310 $ 0 $ 60 $ 261 $ (11)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (102)     (102)  
Shares issued in connection with vesting of restricted stock units (in shares)   645,206      
Shares withheld to cover employee taxes on vested restricted stock units (in shares)   (200,735)      
Shares withheld to cover employee taxes on vested restricted stock units (3)   (3)    
Unrealized gain (loss) from cash flow hedges, net of tax $ 1       1
Restricted stock unit repurchases (in shares)   (20,368)      
Stock option exercised (in shares) 2,202,895 2,202,895      
Stock option exercises $ 3   3    
Stock-based compensation 11   11    
Issuance of common stock upon initial public offering, net of offering costs, underwriting discounts and commissions (in shares)   15,000,000      
Issuance of common stock upon initial public offering, net of offering costs, underwriting discounts and commissions 267   267    
CARES Act warrants 43   43    
Ending balance (in shares) at Dec. 31, 2021   217,065,096      
Ending balance at Dec. 31, 2021 530 $ 0 381 159 (10)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (37)     (37)  
Shares issued in connection with vesting of restricted stock units (in shares)   845,606      
Shares withheld to cover employee taxes on vested restricted stock units (in shares)   (312,541)      
Shares withheld to cover employee taxes on vested restricted stock units (4)   (4)    
Unrealized gain (loss) from cash flow hedges, net of tax 4        
Amortization of cash flow hedges, net of tax 1       1
Unrealized gain from cash flow hedges, net of tax $ 3       3
Stock option exercised (in shares) 277,729 277,729      
Stock option exercises $ 1   1    
Stock-based compensation $ 15   15    
Ending balance (in shares) at Dec. 31, 2022 217,875,890 217,875,890      
Ending balance at Dec. 31, 2022 $ 509 $ 0 393 122 (6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (11)     (11)  
Shares issued in connection with vesting of restricted stock units (in shares)   1,243,909      
Shares withheld to cover employee taxes on vested restricted stock units (in shares)   (443,720)      
Shares withheld to cover employee taxes on vested restricted stock units (5)   (5)    
Unrealized gain (loss) from cash flow hedges, net of tax (1)        
Amortization of cash flow hedges, net of tax 1       1
Unrealized gain from cash flow hedges, net of tax $ (2)       (2)
Stock option exercised (in shares) 4,322,711 4,322,711      
Stock option exercises $ 1   1    
Stock-based compensation $ 14   14    
Ending balance (in shares) at Dec. 31, 2023 222,998,790 222,998,790      
Ending balance at Dec. 31, 2023 $ 507 $ 0 $ 403 $ 111 $ (7)